Jennifer Chien

Jennifer Chien has more than 20 years of commercial leadership experience in the biopharmaceutical industry. Most recently, she was vice president, head of genetic diseases at Sanofi Genzyme where she was responsible for the U.S. commercial strategy and implementation for seven brands and preparation for upcoming launches within rare diseases. During her tenure at Sanofi Genzyme, she also held global leadership roles as VP, head of global nephrological diseases, senior director global marketing Fabry disease, senior director global market access and international marketing for the cardiovascular business, in addition to leading business development efforts within various therapeutic areas. Jennifer holds a B.S. degree from Massachusetts Institute of Technology and a MPH degree from Harvard University.